Catalyst
Slingshot members are tracking this event:
Clovis (CLVS) Expects to Begin Phase 3 TRITON3 Study in Q1 Comparing Rucaparib to Physicians Choice of AR-Targeted Therapy or Chemotherapy in Treatment of Patients with Tumor BRCA Mutations and ATM Mutations
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLVS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 03, 2017
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-newsArticle&ID=2269437
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Triton3, Rucaparib
